Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Subcutaneous Immunoglobulins Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Aug-2018
No. of pages: 113

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Scope of the Report:

This report focuses on the Subcutaneous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.

Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Subcutaneous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Shire (Baxalta)

- Grifols

- CSL

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 10% Purity

- 20% Purity

Market Segment by Applications, can be divided into

- Primary Immunodeficiency

- Secondary Immunodeficiency

- Others

There are 15 Chapters to deeply display the global Subcutaneous Immunoglobulins market.

Chapter 1, to describe Subcutaneous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Subcutaneous Immunoglobulins, with sales, revenue, and price of Subcutaneous Immunoglobulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Subcutaneous Immunoglobulins, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Subcutaneous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Subcutaneous Immunoglobulins Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Subcutaneous Immunoglobulins Introduction
1.2 Market Analysis by Type
1.2.1 10% Purity
1.2.2 20% Purity
1.3 Market Analysis by Applications
1.3.1 Primary Immunodeficiency
1.3.2 Secondary Immunodeficiency
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Business Overview
2.1.1.1 Shire (Baxalta) Description
2.1.1.2 Shire (Baxalta) Headquarter, Main Business and Finance Overview
2.1.2 Shire (Baxalta) Subcutaneous Immunoglobulins Product Introduction
2.1.2.1 Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
2.1.2.2 Subcutaneous Immunoglobulins Product Information
2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Shire (Baxalta) Subcutaneous Immunoglobulins Market Share in 2017
2.2 Grifols
2.2.1 Business Overview
2.2.1.1 Grifols Description
2.2.1.2 Grifols Headquarter, Main Business and Finance Overview
2.2.2 Grifols Subcutaneous Immunoglobulins Product Introduction
2.2.2.1 Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
2.2.2.2 Subcutaneous Immunoglobulins Product Information
2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Grifols Subcutaneous Immunoglobulins Market Share in 2017
2.3 CSL
2.3.1 Business Overview
2.3.1.1 CSL Description
2.3.1.2 CSL Headquarter, Main Business and Finance Overview
2.3.2 CSL Subcutaneous Immunoglobulins Product Introduction
2.3.2.1 Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
2.3.2.2 Subcutaneous Immunoglobulins Product Information
2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global CSL Subcutaneous Immunoglobulins Market Share in 2017
3 Global Subcutaneous Immunoglobulins Market Competition, by Manufacturer
3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Subcutaneous Immunoglobulins Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017
3.4.2 Top 5 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Subcutaneous Immunoglobulins Market Analysis by Regions
4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions
4.1.1 Global Subcutaneous Immunoglobulins Sales by Regions (2013-2018)
4.1.2 Global Subcutaneous Immunoglobulins Revenue by Regions (2013-2018)
4.2 North America Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2013-2018)
5 North America Subcutaneous Immunoglobulins by Countries, Type, Application and Manufacturers
5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
5.1.1 North America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
5.1.2 North America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
5.1.3 United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
5.1.4 Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
5.1.5 Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
5.2 North America Subcutaneous Immunoglobulins Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Subcutaneous Immunoglobulins Sales by Manufacturers (2016-2017)
5.2.2 North America Subcutaneous Immunoglobulins Revenue by Manufacturers (2016-2017)
5.3 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Subcutaneous Immunoglobulins Sales and Sales Share by Type (2013-2018)
5.3.2 North America Subcutaneous Immunoglobulins Revenue and Revenue Share by Type (2013-2018)
5.4 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Subcutaneous Immunoglobulins Sales and Sales Share by Application (2013-2018)
5.4.2 North America Subcutaneous Immunoglobulins Revenue and Revenue Share by Application (2013-2018)
6 Europe Subcutaneous Immunoglobulins by Countries, Type, Application and Manufacturers
6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
6.1.2 Europe Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
6.1.3 Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
6.1.4 UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
6.1.5 France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
6.1.6 Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
6.1.7 Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
6.2 Europe Subcutaneous Immunoglobulins Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Subcutaneous Immunoglobulins Sales by Manufacturers (2016-2017)
6.2.2 Europe Subcutaneous Immunoglobulins Revenue by Manufacturers (2016-2017)
6.3 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Subcutaneous Immunoglobulins Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Subcutaneous Immunoglobulins Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Subcutaneous Immunoglobulins Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Subcutaneous Immunoglobulins Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Subcutaneous Immunoglobulins by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
7.1.3 China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
7.1.4 Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
7.1.5 Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
7.1.6 India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Subcutaneous Immunoglobulins Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Subcutaneous Immunoglobulins Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Subcutaneous Immunoglobulins Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue and Revenue Share by Application (2013-2018)
8 South America Subcutaneous Immunoglobulins by Countries, Type, Application and Manufacturers
8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
8.1.1 South America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
8.1.2 South America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
8.1.3 Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
8.1.4 Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
8.1.5 Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
8.2 South America Subcutaneous Immunoglobulins Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Subcutaneous Immunoglobulins Sales by Manufacturers (2016-2017)
8.2.2 South America Subcutaneous Immunoglobulins Revenue by Manufacturers (2016-2017)
8.3 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Subcutaneous Immunoglobulins Sales and Sales Share by Type (2013-2018)
8.3.2 South America Subcutaneous Immunoglobulins Revenue and Revenue Share by Type (2013-2018)
8.4 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Subcutaneous Immunoglobulins Sales and Sales Share by Application (2013-2018)
8.4.2 South America Subcutaneous Immunoglobulins Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Subcutaneous Immunoglobulins by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
9.1.4 UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
9.1.5 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
9.1.7 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Subcutaneous Immunoglobulins Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Subcutaneous Immunoglobulins Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Subcutaneous Immunoglobulins Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Subcutaneous Immunoglobulins Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue and Revenue Share by Application (2013-2018)
10 Global Subcutaneous Immunoglobulins Market Segment by Type
10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2013-2018)
10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2013-2018)
10.2 10% Purity Sales Growth and Price
10.2.1 Global 10% Purity Sales Growth (2013-2018)
10.2.2 Global 10% Purity Price (2013-2018)
10.3 20% Purity Sales Growth and Price
10.3.1 Global 20% Purity Sales Growth (2013-2018)
10.3.2 Global 20% Purity Price (2013-2018)
11 Global Subcutaneous Immunoglobulins Market Segment by Application
11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2013-2018)
11.2 Primary Immunodeficiency Sales Growth (2013-2018)
11.3 Secondary Immunodeficiency Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)
12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2018-2023)
12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2018-2023)
12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2018-2023)
12.3.1 Global Subcutaneous Immunoglobulins Sales Forecast by Type (2018-2023)
12.3.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2018-2023)
12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2018-2023)
12.4.1 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2018-2023)
12.4.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Subcutaneous Immunoglobulins Picture
Table Product Specifications of Subcutaneous Immunoglobulins
Figure Global Subcutaneous Immunoglobulins CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Subcutaneous Immunoglobulins CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Subcutaneous Immunoglobulins by Types in 2017
Figure 10% Purity Picture
Table Major Manufacturers of 10% Purity
Figure 20% Purity Picture
Table Major Manufacturers of 20% Purity
Figure Subcutaneous Immunoglobulins Sales Market Share by Applications in 2017
Figure Primary Immunodeficiency Picture
Figure Secondary Immunodeficiency Picture
Figure Others Picture
Figure United States Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure France Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure UK Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure China Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure India Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)
Table Shire (Baxalta) Headquarter, Established, Main Business and Finance Overview (2017)
Table Shire (Baxalta) Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
Table Shire (Baxalta) Subcutaneous Immunoglobulins Product
Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shire (Baxalta) Subcutaneous Immunoglobulins Sales Market Share in 2017
Figure Global Shire (Baxalta) Subcutaneous Immunoglobulins Revenue Market Share in 2017
Table Grifols Headquarter, Established, Main Business and Finance Overview (2017)
Table Grifols Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
Table Grifols Subcutaneous Immunoglobulins Product
Table Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Grifols Subcutaneous Immunoglobulins Sales Market Share in 2017
Figure Global Grifols Subcutaneous Immunoglobulins Revenue Market Share in 2017
Table CSL Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Subcutaneous Immunoglobulins Production Bases, Sales Regions and Major Competitors
Table CSL Subcutaneous Immunoglobulins Product
Table CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Subcutaneous Immunoglobulins Sales Market Share in 2017
Figure Global CSL Subcutaneous Immunoglobulins Revenue Market Share in 2017
Table Global Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Table Global Subcutaneous Immunoglobulins Price by Manufacturer (2016-2017)
Figure Top 3 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017
Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Global Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table Global Subcutaneous Immunoglobulins Sales by Regions (2013-2018)
Table Global Subcutaneous Immunoglobulins Sales Market Share by Regions (2013-2018)
Table Global Subcutaneous Immunoglobulins Revenue by Regions (2013-2018)
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2013
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2017
Figure North America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure North America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Figure Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Figure South America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure South America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Figure North America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2013
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017
Table North America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
Table North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017
Figure United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table North America Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Table North America Subcutaneous Immunoglobulins Sales by Type (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)
Table North America Subcutaneous Immunoglobulins Revenue by Type (2013-2018)
Table North America Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales by Application (2013-2018)
Table North America Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)
Table North America Subcutaneous Immunoglobulins Revenue by Application (2013-2018)
Table North America Subcutaneous Immunoglobulins Revenue Share by Application (2013-2018)
Figure Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)
Table Europe Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017
Figure Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure Europe Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure Europe Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table Europe Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Table Europe Subcutaneous Immunoglobulins Sales by Type (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)
Table Europe Subcutaneous Immunoglobulins Revenue by Type (2013-2018)
Table Europe Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales by Application (2013-2018)
Table Europe Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)
Table Europe Subcutaneous Immunoglobulins Revenue by Application (2013-2018)
Table Europe Subcutaneous Immunoglobulins Revenue Share by Application (2013-2018)
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries 2017
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Countries 2017
Figure China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Type (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Type (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Application (2013-2018)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue Share by Application (2013-2018)
Figure South America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)
Figure South America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017
Table South America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
Table South America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)
Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017
Figure Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure South America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure South America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table South America Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Table South America Subcutaneous Immunoglobulins Sales by Type (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)
Table South America Subcutaneous Immunoglobulins Revenue by Type (2013-2018)
Table South America Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales by Application (2013-2018)
Table South America Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)
Table South America Subcutaneous Immunoglobulins Revenue by Application (2013-2018)
Table South America Subcutaneous Immunoglobulins Revenue Share by Application (2013-2018)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2013-2018)
Table Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017
Table Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)
Table Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017
Figure Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Figure South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)
Table Middle East and Africa Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Manuf
  • Global Inosine Pranobex Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 135
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Inosine Pranobex Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 133
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • 2018-2023 Global PVP Iodine Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 163
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PVP Iodine market for 2018-2023. Povidone-Iodine is a stable chemical complex of Polyvinylpyrrolidone (Povidone, PVP) and elemental Iodine (I). It contains from 9.0% to 12.0% available iodine. And base on the output of the PVP Iodines, the classification of PVP Iodine includes Medical Grade, Industrial Grade, and the proportion of Medical Grade in 20......
  • 2018-2023 Global Varicella Attenuated Live Vaccine Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Varicella Attenuated Live Vaccine market for 2018-2023. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development o......
  • 2018-2023 Global Zika Virus Testing Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 159
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Zika Virus Testing market for 2018-2023. Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosqu......
  • Global and India Inhalation & Nasal Spray Generic Drugs Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 108
    Summary Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by ha......
  • Global Phenylketonuria (PKU) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Aug-2018        Price: US 3480 Onwards        Pages: 132
    Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. Scope of the Report: This report focuses on the Phenylketonuria (PKU) in global mar......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phenylketonuria (PKU) Market 2018, Forecast to 2023
    Published: 16-Aug-2018        Price: US 4880 Onwards        Pages: 128
    Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. Scope of the Report: This report focuses on the Phenylketonuria (PKU) in global mar......
  • Global and India Steroid-Corticosteroids Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 107
    Summary Steroid-Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Market Segment as follows: By Type - Cream - Injection - Others By Application - Hospital - Clinic - Others By Company - Pfizer - Sumitomo - Novartis - Merck - Sanofi - Johnson and Johnson - GSK......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs